Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2022

17-05-2022 | Computed Tomography | Original Article

Ultrafast 30-s total-body PET/CT scan: a preliminary study

Authors: Yiqiu Zhang, Pengcheng Hu, Yibo He, Haojun Yu, Hui Tan, Guobing Liu, Jianying Gu, Hongcheng Shi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2022

Login to get access

Abstract

Purpose

The aim of this study is to explore the diagnostic value of the images obtained in ultrafast 30-s acquisition time by the total-body PET/CT (18F-FDG injection dose of about 3.7 MBq/kg), and to evaluate whether they can meet the requirements of clinical diagnosis or not.

Methods

This retrospective study explored the clinical value of ultrafast 30-s 18F-FDG total-body PET/CT in 88 oncology patients, using the post-surgical pathological diagnosis as the reference standard. The data were acquired over 300 s and reconstructed using all 300-s data (G300) and only the initial 30 s (G30). Two readers independently assessed all images qualitatively and quantitatively. The diagnostic performance was compared between G300 and G30.

Results

The G300 average qualitative score was higher than G30 (P < 0.001). G300 and G30 also differed quantitatively in the liver and mediastinum SUVmax, SD, and SNR (all P < 0.001), but had similar sensitivities (89.09% vs. 86.36%, P = 0.250). The G300 group had higher accuracy (79.73%) and a larger area under the curve (0.709) than G30 (77.70% and 0.695, respectively; all P > 0.05).

Conclusion

The 30-s total-body PET/CT could meet clinical diagnostic requirements for malignant tumors in patients intolerant to prolonged horizontal positioning.
Literature
1.
go back to reference Krause BJ, Schwarzenböck S, Souvatzoglou M. FDG PET and PET/CT. Recent Results Cancer Res. 2013;187:351–69.CrossRef Krause BJ, Schwarzenböck S, Souvatzoglou M. FDG PET and PET/CT. Recent Results Cancer Res. 2013;187:351–69.CrossRef
2.
go back to reference Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD. Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care. J Nucl Med. 2018;59:3–12.CrossRef Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD. Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care. J Nucl Med. 2018;59:3–12.CrossRef
3.
go back to reference Zhang X, Zhou J, Cherry SR, Badawi RD, Qi J. Quantitative image reconstruction for total-body PET imaging using the 2-meter long EXPLORER scanner. Phys Med Biol. 2017;62:2465–85.CrossRef Zhang X, Zhou J, Cherry SR, Badawi RD, Qi J. Quantitative image reconstruction for total-body PET imaging using the 2-meter long EXPLORER scanner. Phys Med Biol. 2017;62:2465–85.CrossRef
4.
go back to reference Tan H, Gu Y, Yu H, et al. Total-body PET/CT: current applications and future perspectives. AJR Am J Roentgenol. 2020;215:325–37.CrossRef Tan H, Gu Y, Yu H, et al. Total-body PET/CT: current applications and future perspectives. AJR Am J Roentgenol. 2020;215:325–37.CrossRef
5.
go back to reference Nardo L, Abdelhafez YG, Spencer BA, Badawi RD. Clinical implementation of total-body PET/CT at University of California. Davis PET Clin. 2021;16:1–7.CrossRef Nardo L, Abdelhafez YG, Spencer BA, Badawi RD. Clinical implementation of total-body PET/CT at University of California. Davis PET Clin. 2021;16:1–7.CrossRef
6.
go back to reference Surti S, Pantel AR, Karp JS. Total body PET: why, how, what for. IEEE Trans Radiat Plasma Med Sci. 2020;4:283–92.CrossRef Surti S, Pantel AR, Karp JS. Total body PET: why, how, what for. IEEE Trans Radiat Plasma Med Sci. 2020;4:283–92.CrossRef
7.
go back to reference Vandenberghe S, Moskal P, Karp JS. State of the art in total body PET. EJNMMI Phys. 2020;7:35.CrossRef Vandenberghe S, Moskal P, Karp JS. State of the art in total body PET. EJNMMI Phys. 2020;7:35.CrossRef
8.
go back to reference Spencer BA, Berg E, Schmall JP, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2–2018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med. 2021;62:861–70.CrossRef Spencer BA, Berg E, Schmall JP, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2–2018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med. 2021;62:861–70.CrossRef
9.
go back to reference Tan H, Sui X, Yin H, et al. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:1966–75.CrossRef Tan H, Sui X, Yin H, et al. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:1966–75.CrossRef
10.
go back to reference Liu G, Hu P, Yu H, et al. Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of 18F-FDG in healthy volunteers. Eur J Nucl Med Mol Imaging. 2021;48:2373–83.CrossRef Liu G, Hu P, Yu H, et al. Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of 18F-FDG in healthy volunteers. Eur J Nucl Med Mol Imaging. 2021;48:2373–83.CrossRef
11.
go back to reference Zhang YQ, Hu PC, Wu RZ, et al. The image quality, lesion detectability, and acquisition time of 18F-FDG total-body PET/CT in oncological patients. Eur J Nucl Med Mol Imaging. 2020;47:2507–15.CrossRef Zhang YQ, Hu PC, Wu RZ, et al. The image quality, lesion detectability, and acquisition time of 18F-FDG total-body PET/CT in oncological patients. Eur J Nucl Med Mol Imaging. 2020;47:2507–15.CrossRef
12.
go back to reference Hu P, Zhang Y, Yu H, et al. Total-body 18F-FDG PET/CT scan in oncology patients: how fast could it be? Eur J Nucl Med Mol Imaging. 2021;48:2384–94.CrossRef Hu P, Zhang Y, Yu H, et al. Total-body 18F-FDG PET/CT scan in oncology patients: how fast could it be? Eur J Nucl Med Mol Imaging. 2021;48:2384–94.CrossRef
13.
go back to reference Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: transforming the role of positron emission tomography. Sci Transl Med. 2017;9:eaaf6169.CrossRef Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: transforming the role of positron emission tomography. Sci Transl Med. 2017;9:eaaf6169.CrossRef
14.
go back to reference Zhang X, Cherry SR, Xie Z, Shi H, Badawi RD, Qi J. Subsecond total-body imaging using ultrasensitive positron emission tomography. Proc Natl Acad Sci USA. 2020;117:2265–7.CrossRef Zhang X, Cherry SR, Xie Z, Shi H, Badawi RD, Qi J. Subsecond total-body imaging using ultrasensitive positron emission tomography. Proc Natl Acad Sci USA. 2020;117:2265–7.CrossRef
15.
go back to reference Abgral R, Bourhis D, Salaun PY. Clinical perspectives for the use of total body PET/CT. Eur J Nucl Med Mol Imaging. 2021;48:1712–8.CrossRef Abgral R, Bourhis D, Salaun PY. Clinical perspectives for the use of total body PET/CT. Eur J Nucl Med Mol Imaging. 2021;48:1712–8.CrossRef
16.
go back to reference Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95.PubMed Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95.PubMed
17.
go back to reference Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRef Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRef
18.
go back to reference Xiao J, Yu H, Sui X, et al. Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by 18F-FDG total-body PET/CT imaging. Eur J Nucl Med Mol Imaging. 2021;49:269–78.CrossRef Xiao J, Yu H, Sui X, et al. Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by 18F-FDG total-body PET/CT imaging. Eur J Nucl Med Mol Imaging. 2021;49:269–78.CrossRef
19.
go back to reference Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519–27.PubMed Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519–27.PubMed
20.
go back to reference Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging. 2005;32:294–301.CrossRef Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging. 2005;32:294–301.CrossRef
21.
go back to reference Lodge MA, Chaudhry MA, Wahl RL. Noise considerations for PET quantification using maximum and peak standardized uptake value. J Nucl Med. 2012;53:1041–7.CrossRef Lodge MA, Chaudhry MA, Wahl RL. Noise considerations for PET quantification using maximum and peak standardized uptake value. J Nucl Med. 2012;53:1041–7.CrossRef
22.
go back to reference Crivellaro C, De Ponti E, Elisei F, et al. Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study. Eur J Nucl Med Mol Imaging. 2018;45:102–9.CrossRef Crivellaro C, De Ponti E, Elisei F, et al. Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study. Eur J Nucl Med Mol Imaging. 2018;45:102–9.CrossRef
23.
go back to reference Kim JY, Kim MH, Lee TY, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol. 2008;103:1145–51.CrossRef Kim JY, Kim MH, Lee TY, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol. 2008;103:1145–51.CrossRef
24.
go back to reference Taralli S, Scolozzi V, Foti M, et al. 18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules. Eur J Nucl Med Mol Imaging. 2019;46:429–36.CrossRef Taralli S, Scolozzi V, Foti M, et al. 18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules. Eur J Nucl Med Mol Imaging. 2019;46:429–36.CrossRef
25.
go back to reference Kubiessa K, Purz S, Gawlitza M, et al. Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41:639–48.CrossRef Kubiessa K, Purz S, Gawlitza M, et al. Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41:639–48.CrossRef
26.
go back to reference Nardo L, Schmall JP, Werner TJ, Malogolowkin M, Badawi RD, Alavi A. Potential roles of total-body PET/computed tomography in pediatric imaging. PET Clin. 2020;15:271–9.CrossRef Nardo L, Schmall JP, Werner TJ, Malogolowkin M, Badawi RD, Alavi A. Potential roles of total-body PET/computed tomography in pediatric imaging. PET Clin. 2020;15:271–9.CrossRef
27.
go back to reference Zhao YM, Li YH, Chen T, et al. Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT. Eur J Nucl Med Mol Imaging. 2021;48:3378–85.CrossRef Zhao YM, Li YH, Chen T, et al. Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT. Eur J Nucl Med Mol Imaging. 2021;48:3378–85.CrossRef
Metadata
Title
Ultrafast 30-s total-body PET/CT scan: a preliminary study
Authors
Yiqiu Zhang
Pengcheng Hu
Yibo He
Haojun Yu
Hui Tan
Guobing Liu
Jianying Gu
Hongcheng Shi
Publication date
17-05-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2022
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05838-1

Other articles of this Issue 8/2022

European Journal of Nuclear Medicine and Molecular Imaging 8/2022 Go to the issue